» Articles » PMID: 33823146

Small Molecule Targeting of Biologically Relevant RNA Tertiary and Quaternary Structures

Overview
Journal Cell Chem Biol
Publisher Cell Press
Specialty Biochemistry
Date 2021 Apr 6
PMID 33823146
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Initial successes in developing small molecule ligands for non-coding RNAs have underscored their potential as therapeutic targets. More recently, these successes have been aided by advances in biophysical and structural techniques for identification and characterization of more complex RNA structures; these higher-level folds present protein-like binding pockets that offer opportunities to design small molecules that could achieve a degree of selectivity often hard to obtain at the primary and secondary structure level. More specifically, identification and small molecule targeting of RNA tertiary and quaternary structures have allowed researchers to probe several human diseases and have resulted in promising clinical candidates. In this review we highlight a selection of diverse and exciting successes and the experimental approaches that led to their discovery. These studies include examples of recent developments in RNA-centric assays and ligands that provide insight into the features responsible for the affinity and biological outcome of RNA-targeted chemical probes. This report highlights the potential and emerging opportunities to selectively target RNA tertiary and quaternary structures as a route to better understand and, ultimately, treat many diseases.

Citing Articles

Three- and four-stranded nucleic acid structures and their ligands.

Hashimoto Y, Shil S, Tsuruta M, Kawauchi K, Miyoshi D RSC Chem Biol. 2025; .

PMID: 40007865 PMC: 11848209. DOI: 10.1039/d4cb00287c.


Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA.

Martyr J, Zafferani M, Bailey M, Zorawski M, Montalvan N, Muralidharan D bioRxiv. 2025; .

PMID: 39990451 PMC: 11844376. DOI: 10.1101/2025.02.10.637408.


Novel Quinazoline Derivatives Inhibit Splicing of Fungal Group II Introns.

Fedorova O, Luo M, Jagdmann Jr G, Van Zandt M, Sisto L, Pyle A ACS Chem Biol. 2025; 20(2):378-385.

PMID: 39824511 PMC: 11851433. DOI: 10.1021/acschembio.4c00631.


Post-Docking Refinement of Peptide or Protein-RNA Complexes Using Thermal Titration Molecular Dynamics (TTMD): A Stability Insight.

Dodaro A, Novello G, Menin S, Cavastracci Strascia C, Sturlese M, Salmaso V J Chem Inf Model. 2025; 65(3):1441-1452.

PMID: 39818831 PMC: 11815843. DOI: 10.1021/acs.jcim.4c01393.


Targeting MicroRNAs with Small Molecules.

Tadesse K, Benhamou R Noncoding RNA. 2024; 10(2).

PMID: 38525736 PMC: 10961812. DOI: 10.3390/ncrna10020017.


References
1.
Shen X, Corey D . Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs. Nucleic Acids Res. 2017; 46(4):1584-1600. PMC: 5829639. DOI: 10.1093/nar/gkx1239. View

2.
Ahn D, Lee W, Choi J, Kim S, Plant E, Almazan F . Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication. Antiviral Res. 2011; 91(1):1-10. PMC: 4728714. DOI: 10.1016/j.antiviral.2011.04.009. View

3.
Palacino J, Swalley S, Song C, Cheung A, Shu L, Zhang X . SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nat Chem Biol. 2015; 11(7):511-7. DOI: 10.1038/nchembio.1837. View

4.
Breaker R . Riboswitches and the RNA world. Cold Spring Harb Perspect Biol. 2010; 4(2). PMC: 3281570. DOI: 10.1101/cshperspect.a003566. View

5.
Thulson E, Hartwick E, Cooper-Sansone A, Williams M, Soliman M, Robinson L . An RNA pseudoknot stimulates HTLV-1 programmed -1 ribosomal frameshifting. RNA. 2020; 26(4):512-528. PMC: 7075266. DOI: 10.1261/rna.070490.119. View